3 very impressive ASX quarterly updates from last week

ResMed Inc (ASX:RMD) and these ASX shares have just delivered very impressive quarterly updates. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While earnings season hasn't officially started, a number of companies have just released their quarterly updates.

Here's a summary of three standout updates from last week:

ASX share price on watch represented by woman investor looking at ASX financial results on laptop

Image source: Getty Images

Bigtincan Holdings Ltd (ASX: BTH)

This artificial intelligence-powered sales enablement automation platform provider delivered a strong second quarter update last week. That update revealed that Bigtincan's strong form continued during the quarter, with annualised recurring revenue (ARR) increasing to $48.4 million. This represents growth of 50% on the prior corresponding period. It was driven predominantly by organic growth. Organic ARR came in at $40 million (up 42.9%) and ARR from acquisitions came in at $8.4 million.

Nitro Software Ltd (ASX: NTO)

Another impressive performer during the last quarter was this document productivity software company. Last week it released its fourth quarter update and revealed that its ARR reached US$27.7 million at the end of December. This was up 64% on the prior corresponding period and ahead of its previously upgraded guidance of US$26 million to US$27 million. Another positive was the increasing amount of revenue which is now from subscriptions. At the end of the period, subscription revenue had increased to approximately 58% of total revenue. It also comprised approximately 78% of revenue across the dominant Business sales channel.

ResMed Inc (ASX: RMD) 

A final result that caught the eye was the second quarter update from this medical device company. ResMed delivered a 9% increase in quarterly revenue to US$800 million and a 17% increase in net profit to US$206.4 million. This was ahead of the analyst consensus estimate for both revenue and earnings. Management advised that its growth was driven by a solid performance across the business. This includes its digital health business, which has been performing strongly thanks to the growing importance of out-of-hospital care.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends BIGTINCAN FPO. The Motley Fool Australia owns shares of and has recommended BIGTINCAN FPO. The Motley Fool Australia has recommended Nitro Software Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A boy bounds after a big colourful bouncing ball in a grassy field.
Share Market News

ASX 200 energy shares lead and market finally cracks 8-day losing streak

The ASX 200's painful 8-day slide finally ended on Friday.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Mesoblast, Mineral Resources, and Woolworths shares

Analysts have given their verdict on these shares. Let's see what they are saying.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These top ASX 200 shares could rise 30% to 40%

Analysts are predicting big things from these shares. Let's find out why.

Read more »

Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.
Dividend Investing

How I'd invest $2,000 in high-yield ASX 300 shares

I rate these businesses as strong buys for the long-term.

Read more »

A rueful woman tucks into a sweet pie as she contemplates a decision with regret.
Share Fallers

The worst 4 ASX 200 stocks to buy and hold in April unmasked

Investors sent these four ASX 200 stocks tumbling 21% to 44% in April.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Share Fallers

Why these top ASX shares sank 10%+ in April

It was a tough month for these popular shares.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today
Share Market News

Buy, hold, sell: Capricorn Metals, PLS Group, Fortescue shares

Bell Potter has reviewed its ratings and 12-month price targets on three ASX 200 mining shares.

Read more »